To investigate the relationship between natural killer (NK) cells and traumatic brain injury (TBI), we tracked an established phenotype of circulating NK cells at several time points in patients with different grades of TBI. In serial peripheral blood samples, NK cells were prospectively measured by flow cytometry of CD3 -
INTRODUCTION
Traumatic brain injury (TBI), a major cause of neurological disability and death, is a public health problem and an enormous financial burden world-wide [1] [2] [3] [4] [5] . In addition to the adverse effects on the central nervous system (CNS), unfavorable outcomes of TBI often stem from extracranial complications. That is, injury-induced damage to the CNS can suppress the immune system and result, most commonly, in fever, pneumonia, and urinary tract infections [6, 7] . This immune-defi ciency syndrome increases these patients' susceptibility to infections, although the u nderlying mechanism has not been identifi ed [8, 9] . N atural killer (NK) cells are the first line of defense to combat infections, and they are one of the earliest cell types to arrive at target organs of inflammation.
NK cells can affect the initiation of autoimmunity and regulate inflammation [10] [11] [12] . Under certain pathological circumstances, NK cells can home readily to the CNS [10] .
Therefore, the functions of NK cells have become a growing focus of interest, particularly with regard to their roles as regulators of autoimmunity and inducers of inflammatory responses in animal models and in humans [13] . H owever, the extent to which NK cells modulate inflammatory responses in specifi c organs has not been characterized.
Whether NK cells are simply passive migrants or active participants in the pathogenesis of CNS injury is a complex and sometimes even paradoxical issue [11, 14] .
Previous studies have revealed an early decrease of NK-cell function in patients with septic or severe TBI [15, 16] .
criteria were an undetermined time of injury, spinal cord injury, recipients of blood transfusion or steroid treatment, massive abdominal and/or chest injuries requiring surgery, death during hospitalization, inability to perform follow-up, or any immunodefi ciency on admission.
All enrolled patients or their caregivers provided written informed consent before enrollment in the study.
The inclusion criteria for each patient were approved, as designated in a stan dardized trial protocol designed by the Ethics Commit tee of Tianjin Neurological Institute. As
recommended by the Guidelines for the Management of
Severe Traumatic Brain Injury (3rd edition) [19] , all patients received standard care from the time of enrollment onward. To avoid the confounding effects of aging and related diseases, patients older than 60 years of age were excluded. No patient used any drug affecting hypothalamicpituitary function, and none was treated with steroids, as suggested in the Guidelines for Management (XV) [19] .
Classifi cation of TBI
Structural damage was rated by the Marshall Classifi cation on computed tomography (CT) scans [20] . Class I indicates no visible pathology; class II, cisterns present, with a midline shift of ≤5 mm and no lesions >25 mL; class III, cisterns compressed or absent, with a midline shift of ≤5 mm and no lesions >25 mL; class IV, a midline shift of >5 mm; and class V, a lesion requiring surgical evacuation [4, 21, 22] .
All patients with closed head injuries who had a GCS score of 3 to 15 were admitted to our trauma center, and the locations of brain injury were recorded at that time.
NK Cell Isolation and Analysis
To quantify NK cells in the circulation, peripheral blood mononuclear cells (PBMCs) were separated from fresh blood samples as described [14, 23] . Then 2 mL of PBMCs was subjected to density gradient centrifugation at 300 g for 20 min at room temperature. The NK cells thus purifi ed were washed three times with phosphate-buffered saline (PBS; + lymphocytes for further analysis [15, 24] . A FACSCalibur cytometer (Becton Dickinson, Mountain View, CA) was used, and the data were analyzed with FlowJo software (Tree Star, Inc., Ashland, OR).
Assessment of Neurological Outcome
Primary neurological outcomes were assessed with the Glasgow O utcome Scale (GOS) [25] . GOS scores are: 1, death; 2, vegetative state; 3, severe disability (unable to live independently); 4, moderate disability (capable of living independently); and 5, mild or no disability [21] . Outcome measures were assessed at 3 and 6 months after injury by a specialist trained in physical medicine and rehabilitation who was unaware of group assignments. No patients were lost to follow-up.
Serum Cortisol Assay
Hormone assays were performed at increasing intervals after the diagnosis of TBI in the groups scored as moderately and severely disabled. The serum cortisol levels were measured using an enzymatic immunoassay under a protocol approved by the Tianjin Medical University
General Hospital Clinical Laboratory. Normal morning serum cortisol concentrations are 5 to 21 μg/dl [26] .
Statistical Analysis
The Correlations between NK cells and GCS/GOS were evaluated using Spearman correlation coefficients (r). P ≤0.05 was considered to be statistically signifi cant.
RESULTS

Clinical Characteristics of Patients with TBI
The clinical baseline features of patients with TBI are summarized in Table 1 . Among the mild, moderate, and severe TBI groups, no signifi cant difference was found in the initial data for age, gender, medical history, and smoking or drinking history. Most patients were male, and a motor-vehicle accident was the most common cause of injury. However, these groups had signifi cant differences in leucocyte counts and body temperatures on admission. In the group with mild TBI, the initial GCS score was 13 to 15. The group with moderate TBI had an initial GCS score from 9 to 12, and the initial GCS score of those with severe TBI was 5 to 8. The average length of stay in the trauma center for each group was at least 21 days. No patients were lost to follow-up.
A neuroradiologist reviewed all CT scans, and classification was based on the initial CT findings ( Table   2 ). Our study excluded the recording of penetrating head injuries and the severity of extracranial injuries. Mild TBI could be isolated, but complex traumatic intracranial lesions occurred frequently in the groups with moderate and severe TBI ( Table 2 ) [4] . All individuals with normal fi ndings on CT scans (class I) and patients who required surgery (class V)
were excluded on admission.
Changes of Peripheral NK Cells after TBI
The percentages of CD3 -CD56 + NK cells (% of total lymphocytes) fi rst decreased and then increased after injury compared with the levels in healthy controls ( (Fig. 1A and 1a ). In the moderate TBI group, the percentages and absolute numbers of NK cells were lower than those in controls on day 7 after injury (Z = -3.740, P = 0.000 and Z = -4.334, P <0.001). The percentage of NK cells remained below the normal level on post-injury day 21
(Z = -1.980, P = 0.048) (Fig. 1B) , but the absolute numbers of these cells normalized at this time point (Z = -1.078, P = 0.281) (Fig. 1b) . In patients with severe TBI, the lowest percentages and absolute numbers of CD3 -CD56 + NK cells were found on days 3 and 7 in comparison with other days and controls (Z = -3.608, P <0.001 and Z = -4.399, P <0.001 on day 3; Z = -3.872, P <0.001 and Z = -4.399, P <0.001 on day 7) (Fig. 1C and 1c) . In addition, the percentages and absolute numbers of CD3 -CD56 + NK cells among PBMCs did not return to normal by follow-up day 21 (Z = -2.860, P = 0.004 and Z = -3.959, P <0.001) ( Figure 1C and 1c) .
Neurological Outcome
The neurological outcome (unfavorable functional status and survival) for each participant was assessed at 3 and 6 months after TBI diagnosis using the GOS (Table 3) . At 3 months, 9 (90%) of the mild TBI patients had a GOS score of 4 or 5, in contrast to the 7 (70%) in the moderate TBI group and 6 (60%) with severe TBI. At 6 months, all of the mild TBI patients had a GOS score of 4 or 5, whereas those in the moderate and severe TBI groups retained their 3-month scores (Table 3) .
Correlation between NK and GCS
Bivariate correlation analysis showed that lower percentages and absolute numbers of CD3 -CD56 + NK cells both aligned with a low GCS score on days 7, 14, and 21 but not at any other time point (Fig. 2) . 
Correlation between NK and GOS
In PBMC samples collected on days 1, 7, and 14 post-TBI, the percentages as well as the absolute numbers of NK cells were both associated with low GOS scores at 3 months after TBI (Fig. 3A, B) . At 6 months after injury, the lower percentages of NK cells concurred with lower GOS scores on days 7 and 14 ( Fig. 3C) . Clearly, the absolute numbers of NK cells correlated well with the GOS on days 1, 7, and 14 after the injury (Fig. 3D) .
Changes of Serum Cortisol
The serum cortisol concentrations did not fall below the 95% confi dence limit in any patient following moderate or severe TBI. However, patients with moderate or severe TBI had a borderline response of cortisol values, which peaked on day 1 and fell close to the 95% confi dence limits on day 3 (Fig. 4) .
Fig. 1. Percentages and absolute numbers of NK cells among PBMCs of patients with traumatic brain injury (TBI) and healthy volunteers
DISCUSSION
Although immune dysfunction associated with CNS injury has been reported [27] , and NK cells are known to occupy the CNS following brain trauma, the critical issues of how NK cells recruit the agents of infection and function during immunodefi ciency are not well understood [8, 28] . Accordingly, we investigated the characteristics of NK cells during the course of closed head injury and recorded dramatic alterations of these innate immune cells in peripheral blood.
Having the ability to lyse target cells without the need for prior antigen stimulation, NK cells are important effectors of innate immunity [24, 29, 30] . They can promote or inhibit adaptive immune responses [30, 31] . The average value for CD3
-CD56 + NK cell content among PBMCs from healthy volunteers was ~11% in our study, in complete agreement with previous reports [15, 30] , and the absolute number of CD3 -CD56 + cells among PBMCs from healthy volunteers was 205/mm 3 (170-298), similar to that published by Forel et al. [15] . In the present study, we evaluated the relationship between NK cell content and different degrees of TBI.
Flow cytometry revealed a signifi cant reduction of the CD3 In this study, on day 3 after TBI, all patients had a prominent decrease in the absolute numbers of CD3 -CD56 + NK cells. It has been reported that severe CNS injury precipitates significant deficiencies of immune function within 72 h [17] . In accord with this, Piek et al. found that infections begin most frequently 2 to 4 days after TBI, peaking from days 5 to 11 [7] . Immunosuppression may account for the high rate of infection in these patients.
Our investigation clearly showed small numbers of CD3 -CD56 + NK cells in PBMC around the peak time of infection, presumably representing the least effective immune function. Such a depletion of NK cells might have evolved to control excessive autoimmunity [32] . In addition, the decreased NK cells recovered on day 7 in patients with mild TBI, and on day 21 in those with moderate TBI.
However, NK cells in patients with severe TBI did not return to the normal level. An intact hypothalamic-pituitary-adrenal (HPA) axis with effective anti-inflammatory activity is indispensable for host survival of critical illness [34] . Post-traumatic hypopituitarism and hypothalamo-pituitary dysfunction are common and potentially serious complications of TBI [2] . Dysfunction of the HPA axis is known to result in critical corticosteroid insuffi ciency [34] . However, most available evidence indicates that steroid therapy does not improve the outcome in patients with severe TBI. In fact, the administration of steroids has a deleterious effect; so, their use is not recommended for TBI [19] .
In anticipation that steroid levels might impact our results, only patients who had not used steroids were enrolled. In all patients with moderate or severe TBI, morning serum cortisol concentrations were checked and were well within the normal range, in agreement with the preliminary study of Mrakovcic et al. [16] . The cortisol concentrations fell to borderline low values on day 3 after TBI, and the changes resembled those of NK cells. However, cortisol can suppress the immune system and directly inhibit NK cell activity, as described in some reports [35] [36] [37] . Therefore, we cannot yet eliminate the possibility that changes of NK cell number were the consequence of stress cortisol imbalance in our patients. Moreover, activation of the sympathetic and parasympathetic nervous systems can trigger the conditioned NK cell response [38, 39] . Further, damage or stimulation of some limbic structures can signifi cantly affect the cytotoxic capacity of NK cells [40] . It has been shown that lesions of limbic structures in rats cause a gradual depression of the cytotoxicity of NK cells, which peaks 10 days after the initial event, followed by recovery to the baseline on day 21
or later [40] . This result is similar to that in our preliminary study.
Evidently then, injury to the brain, regardless of the specifi c location or cause, can impact NK cells. could become receptive to an array of cellular components that they had not encountered in the periphery [11] . NK cells in the infl amed CNS can directly lyse microglia to inhibit the activation of autoimmune T-cells [14, 23] . In summary, how NK cells act to modulate infl ammatory responses in CNS injury is not completely known, partially because the CNS is uniquely complex as compared with other organ systems [41] . However, we found a significantly 
